In Vivo Optical Imaging of Alpha-Synuclein Aggregation
In Vivo Optical Imaging of Alpha-Synuclein Aggregation
批准号:
9791004
负责人:
Kevin J Webb
金额:
$22.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2021-08-31
关键词:
AddressAnimal ModelAnimalsAreaBrainBrain InjuriesBrain StemBrain imagingCell Culture TechniquesCell secretionChemistryComplexDataDevelopmentDiseaseDisease ProgressionEconomic BurdenEvaluationEvolutionFluorescenceFluorescence Resonance Energy TransferGeneticGoalsHealthHumanImageIn VitroLabelLightLinkMapsMeasurementMedical ResearchMedicineMethodsMicroscopeModelingMolecularMolecular BiologyMolecular ConformationMonitorMovement DisordersNerve DegenerationNeurodegenerative DisordersNeuronal DysfunctionNeuronsNeurosciencesOnset of illnessOpticsParkinson DiseasePathogenesisPathogenicityPathway interactionsPatientsPerformancePlant RootsPlayPrevalenceProteinsRattusResearchResolutionSignal TransductionTimeTissuesUnited StatesUniversitiesValidationWorkalpha synucleinanimal imagingbasedisorder riskeffective therapyexperimental studyfluorescence imagingfluorophorehealth applicationimaging approachimaging modalityimaging studyin vivoin vivo imagingin vivo optical imaginginsightlight scatteringmicroscopic imagingmolecular imagingmotor symptomnanometerneuron lossnovel therapeutic interventionoptical imagingpresynapticprogramsprotein aggregateprotein aggregationprotein foldingpublic health relevancesuccesstissue phantom
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
In Vivo Optical Imaging of Alpha-Synuclein Aggregation
Kevin Webb, J. Chris Rochet, and Jason Cannon, Purdue University
This project entails the application of a high resolution whole brain optical molecular imaging method to determine
the pathogenic mechanism involved in the temporal and spatial development of Parkinson's disease (PD). PD
is a debilitating movement disorder afflicting 5 million people worldwide that imposes an economic burden of
more than $14 billion each year in the United States alone. While the causes of most cases are unknown,
environmental and genetic factors have been repeatedly linked to increased PD risk. Abnormal aggregation of
the presynaptic protein alpha-synuclein (aSyn) is thought to play a key role in PD pathogenesis. Aggregation is
postulated to occur at an early stage in the brain stem, and then in later stages in specific areas of the brain
where neuronal loss or dysfunction results in the cardinal motor symptoms. Although the mechanism by which
aSyn aggregation migrates throughout the brain is not well understood, there is evidence that cell secretion
pathways are involved. We will optically image states of aSyn aggregation throughout the whole living brain at
high spatial resolution and at different times of aSyn expression, presenting a basis for achieving critically needed
understanding related to PD onset and progression. The approach will use our recent discovery of a method to
form images with unprecedented spatial resolution from highly scattered light and our earlier discovery of how
to image fluorescence resonance energy transfer (FRET) in vivo. Completion of this project will enable us to
extract critical insights into the time-course and extent of aSyn propagation throughout the brain, as well as the
aggregation state of transmitted aSyn species, in a live animal model. Knowing the basis for progression of PD
will provide opportunities for the development of early-stage treatment, before substantial brain damage occurs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optical Imaging of Targeted Anti-Cancer Drug Delivery Kinetics
-
批准号:8996138
-
项目类别:
-
资助金额:$16.75万
-
财政年份:2015
-
负责人:Kevin J Webb
-
依托单位:
海外基金